Avon Foundation for Women Breast Cancer Grants
The Avon Foundation for Women continues its search for new preventive strategies to address the growing number of breast cancer cases around the globe. To develop new strategies to prevent breast cancer, we need to understand the causes of breast cancer in people, changes in breast cells that give rise to cancer, markers for disease, and how breast cancer progresses. The 2013 Avon Foundation Research Program seeks proposals in these areas to advance understanding of causes of breast cancer and prevention.
How to Apply
For 2013, there is one-application cycle and a two-stage application process
•Stage 1: Letter-of-Intent (LOI) – Open to all research organizations: universities, nonprofit organizations, or in rare instances, for-profit organizations.
•Stage 2: Full Proposal – By invitation only, based on the review of your LOI submission.
A Letter of Intent is completed using the online system. Only Letters of Intent received via the online system will be considered. Only a small subset of LOIs received will be invited to submit a full proposal.
Letter-of-Intent (LOI) Due Date: Feb. 4, 2013
Only a small subset of LOI submissions will be invited to submit a full proposal.
Proposals may request up to $150,000 total costs per year (this limit is inclusive of 10% indirect costs), for up to two years in duration. Thus, the total award budget can be up to $300,000 to cover up to two years duration.
Applications involving multiple institutions or collaborators in need of a higher level of funding may contact the Avon Foundation to inquire whether an increased amount may be requested. A detailed budget and budget justification are required in the online application.
Research questions we hope to answer to further the development of breast cancer prevention strategies include, but are not limited to, the following:
•Understanding the potential causes of breast cancer and research to develop new preventative strategies
•Understanding the role of endogenous and exogenous environmental factors in the development of breast cancer
•Understanding whether viruses or infectious agents play a role in breast cancer
•Validation of markers/biomarkers of breast cancer risk
•Development or validation of clinically applicable assays or diagnostic tests that are predictive of breast cancer risk or that can be used to monitor changes in breast over time